Blogs about: Nuclear Receptor
Featured Blog
Repros announce completion of Phase II enrollment in Proellex trial
Repros Therapeutics have announced that they now have sufficient patients currently enrolled to provide for adequate power calculations for the Phase III endometriosis trials. … more →
Nuclear Receptor News
Repros announce completion of Phase II enrollment in Proellex trial
crimsoncanary wrote 1 month ago: Repros Therapeutics have announced that they now have sufficient patients currently enrolled to prov … more →
PregLem initiate Phase III trial of SPRM PGL-4001
crimsoncanary wrote 1 month ago: PregLem have announced that it is initiating a Phase III trial of its selective progesterone recepto … more →
Seretide®/Advair treatment effective in COPD
crimsoncanary wrote 1 month ago: Study results show that treatment with Seretide/Advair (salmeterol/fluticasone propionate ) slows … more →
Eprotirome effective in Phase II trial
crimsoncanary wrote 2 months ago: Karo Bio has successfully completed a 12 week phase IIb study of thyroid receptor agonist eprotirome … more →
GTx Announce Phase III Clinical Development of Toremifene on Course
crimsoncanary wrote 2 months ago: GTx have announced that phase III trials of toremifene are on course following a planned safety revi … more →
EU recommends approval of Basileas Toctino (alitretinoin)
crimsoncanary wrote 2 months ago: Basilea Pharmaceutica has announced that Toctino (alitretinoin) has been recommended for approval fo … more →
Hollis-Eden initiate Phase I/II trial of Apoptone in Prostate Cancer
crimsoncanary wrote 2 months ago: Hollis-Eden has commenced a Phase I/II clinical trial with its oral drug candidate Apoptone (HE323 … more →
Proellex shows no potential for tumor induction in a 2 year study
crimsoncanary wrote 2 months ago: Repros Therapeutics have released data frm a two-year study conducted to determine Proellex … more →
Differin Gel approced in Japan for Acne
crimsoncanary wrote 2 months ago: Galderma Pharma have announced that Japan’s Ministry of Health, Labor and Welfare has approve … more →
Mometasone approved in Japan for Allergic Rhinitis
crimsoncanary wrote 2 months ago: Schering-Plough has received marketing approval in Japan for Nasonex (mometasone furoate monohydrate … more →
Proellex shows no adverse effects in long term treatment of Uterine Fibroids
crimsoncanary wrote 2 months ago: Repros Therapeutics have announced that Proellex was found to be safe in the chronic treatment of th … more →
Proellex significantly reduces pain in severe Endometriosis
crimsoncanary wrote 2 months ago: Repros Therapeutics have announced that Phase II data show its Progesterone antagonist Proellex to s … more →
SkyePharmas Third Flutiform Phase III Study meets endpoints
crimsoncanary wrote 3 months ago: SkyePharma have announced that its third Phase III trial of Flutiform in asthma patients has met its … more →
FDA approves Sirion Therapeutics Durezol for postoperative ocular inflammation and pain
crimsoncanary wrote 3 months ago: The FDA has approved Sirion Therapeutics’ topical steroid Durezol for the treatment of postoperat … more →
DuoCort hydrocortisone gets orphan drug designation for adrenal insufficiency
crimsoncanary wrote 3 months ago: DuoCort’s hydrocortisone dual-release oral tablet has been given orphan drug status for the tr … more →
Nippon Shinyaku grants Yoo Young rights to NS-126 in Korea
crimsoncanary wrote 3 months ago: Nippon Shinyaku have granted Yoo Young Pharmaceutical rights to its once daily steroid drug NS-126 f … more →
Repros Therapeutics initiate Phase IIb study of Androxal
crimsoncanary wrote 3 months ago: Repros Therapeutics have initiated a phase IIb clinical study to monitor the effects of Repro … more →
Alizyme has granted an exclusive licence to Norgine for the rights to COLAL-PRED for Ulcerative Colitis
crimsoncanary wrote 3 months ago: Alizyme has granted an exclusive licence to Norgine for the rights to COLAL-PRED in the treatment an … more →
Rosiglitazone delays the onset of Proliferative Diabetic Retinopathy
crimsoncanary wrote 3 months ago: Data publsihed in the Archives of Ophthalmology show that rosiglitazone has been found to delay the … more →
Have your say. Start a blog.
See our free features →
An 
Production
